Quantcast

Latest Bayer HealthCare Pharmaceuticals Inc. Stories

2014-07-25 04:21:37

WHIPPANY, N.J. and SOUTH SAN FRANCISCO, Calif., July 25, 2014 /PRNewswire/ -- Bayer HealthCare and Onyx Pharmaceuticals Inc., an Amgen subsidiary (NASDAQ: AMGN), today announced that an investigational Phase 3 trial of NEXAVAR(®) (sorafenib) tablets in patients with advanced breast cancer did not meet its primary endpoint of improving progression-free survival (PFS). The study, called RESILIENCE, evaluated the efficacy and safety of sorafenib in combination with capecitabine, an...

2014-07-24 08:33:31

WHIPPANY, N.J., July 24, 2014 /PRNewswire-USNewswire/ -- Bayer HealthCare today announced positive results from a Phase III trial that evaluated a 15% foam formulation of its compound azelaic acid (AzA) for the topical treatment of inflammatory papules and pustules of rosacea. An AzA foam formulation is a potential treatment option to complement the currently available AzA gel formulation. Papulopustular rosacea is a skin disease causing inflammatory lesions (papules and pustules) as...

2014-07-09 08:27:56

- Awareness campaign aims to break world record for largest display of origami boats to show widespread support for GIST community WHIPPANY, N.J. and WAYNE, N.J., July 9, 2014 /PRNewswire/ -- To raise awareness about gastrointestinal stromal tumors (GIST), the Life Raft Group, a leading GIST advocacy organization, designates Sunday, July 13, 2014 as worldwide GIST Awareness Day, through a presenting sponsorship from Bayer HealthCare. At the center of the awareness activities is a global...

2014-06-02 23:01:50

Individuals who allege similar pseudotumor injuries associated with use of the Mirena system have asked the U.S. Judicial Panel on Multidistrict Litigation for separate consolidation of their lawsuits. Port Washington, NY (PRWEB) June 02, 2014 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, announces that individuals who have brought lawsuits against Bayer Healthcare Pharmaceuticals Inc. over its Mirena...

2014-06-02 08:31:45

The inserter features a thin, flexible insertion tube and enables single-handed loading WHIPPANY, N.J., June 2, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. today announced Food and Drug Administration (FDA) approval of a new inserter for Mirena(®). Bayer now offers the same inserter design and technique for both Mirena and Skyla(® )(levonorgestrel-releasing intrauterine system) 13.5 mg. (Photo: http://photos.prnewswire.com/prnh/20140531/92968) The innovative Bayer Inserter...

2014-05-14 16:29:06

WHIPPANY, N.J., May 14, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today that data from its oncology portfolio, including NEXAVAR(®) (sorafenib) tablets, Xofigo(®) (radium Ra 223 dichloride) injection and Stivarga(®) (regorafenib) tablets, will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), May 30 - June 3, in Chicago, IL (USA). Bayer will also present data from its late stage clinical pipeline, investigating...

2014-05-12 08:31:01

- Kogenate® FS antihemophilic factor (recombinant) approved for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A WHIPPANY, N.J., May 12, 2014 /PRNewswire/ -- Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication for Bayer's Kogenate® FS antihemophilic factor VIII (recombinant), for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults...

2014-05-09 08:26:43

WHIPPANY, N.J., May 9, 2014 /PRNewswire/ -- Bayer HealthCare was honored by the National Organization for Rare Disorders (NORD) at their annual "Portraits of Courage" Celebration in Washington, DC on May 8. The event recognized several individuals, foundations and innovator companies that have made substantial contributions to improving the lives of people affected by rare disorders. NORD's celebration of progress is an annual event open to everyone with an interest in rare...

2014-04-23 20:23:23

WHIPPANY, N.J. and THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., April 23, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that The Lancet published online results from the Phase 3 DECISION trial which demonstrated that NEXAVAR(®) (sorafenib) tablets significantly extended the time patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma that is...

2014-04-18 23:02:54

Parker Waichman LLP has filed a lawsuit on behalf of a California woman who alleges that her Mirena IUD perforated her uterus, forcing her to undergo surgery to remove the contraceptive device. The lawsuit alleges that Bayer was negligent with regards to Mirena, and points out that the label does not warn about the risk of spontaneous migration or perforation. New York, NY (PRWEB) April 18, 2014 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related